According to the MHRA-approved product information, these include: Nausea (very common, affecting more than 1 in 10 patients) Vomiting and diarrhoea (common, affecting up to 1 in 10 patients) Abdominal pain and constipation (common) Decreased appetite (common) These gastrointestinal symptoms typically occur during the initial weeks of treatment or following dose escalation and often diminish over time as the body adjusts to the medication
Zepbound vs Ozempic side effects Ozempic and Zepbounds side effects are quite similar, including common gastric-related side effects like: vomiting nausea diarrhea constipation abdominal pain heartburn These side effects usually occur when you start the medicine or change dosage and subside as your body adjusts to the new dose
Tirzepatide for weight loss is FDA-approved, but only under the brand name Zepbound, which received approval in November 2023 for chronic weight management among adults with obesity or overweight with related health conditions
Type 1 diabetes should not be a barrier to treating the disease of obesity effectively with obesity medications, Al Ozairi and le Roux said
Psychiatry 83 , 235243 (2018)
Many users report fewer GI side effects when injecting in the thigh